Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,586.00
Bid: 1,586.50
Ask: 1,587.50
Change: -32.00 (-1.98%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Bernstein Raises Tesco And Cuts Morrisons

Mon, 08th Sep 2014 08:35

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BERNSTEIN RAISES TESCO TO 'MARKET-PERFORM' ('UNDERPERFORM') - PRICE TARGET 235 PENCE
----------
BERNSTEIN CUTS MORRISON TO 'UNDERPERFORM' ('MARKET-PERFORM') - PRICE TARGET 140 (180) PENCE
----------
CS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1475) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES BARCLAYS PRICE TARGET TO 300 (285) PENCE - 'BUY'
----------
JPMORGAN RAISES BARRATT DEVELOPMENTS TO 'OVERWEIGHT.' ('NEUTRAL') - PT 460 (440) PENCE
----------
JPMORGAN RAISES INTU PROPERTIES PRICE TARGET TO 340 (305) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PERSIMMON PRICE TARGET TO 1650 (1570) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS DIAGEO PRICE TARGET TO 1730 (1760) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS HARGREAVES LANSDOWN PRICE TARGET TO 850 (950) PENCE - 'UNDERWEIGHT'
----------
CITIGROUP RAISES RECKITT BENCKISER PRICE TARGET TO 6000 (5700) PENCE - 'BUY'
----------
FTSE 250
----------
JEFFERIES RAISES BODYCOTE PRICE TARGET TO 835 (825) PENCE - 'BUY'
----------
LIBERUM RAISES CARILLION PRICE TARGET TO 440 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS PREMIER OIL PRICE TARGET TO 420 (495) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS AFREN PRICE TARGET TO 130 (175) PENCE - 'HOLD'
----------
JPMORGAN RAISES BELLWAY PRICE TARGET TO 2100 (2000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BERKELEY GROUP PRICE TARGET TO 2900 (2800) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BOVIS HOMES PRICE TARGET TO 1000 (950) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS REDROW PRICE TARGET TO 330 (365) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES JLT GROUP PRICE TARGET TO 1260 (1180) PENCE - 'OVERWEIGHT'
----------
CITIGROUP CUTS SYNERGY HEALTH TO 'NEUTRAL' ('BUY') - TARGET 1600 (1145) PENCE
----------
NUMIS RAISES JUPITER FUND TO 'BUY' ('ADD') - TARGET 480 (475) PENCE
----------
NUMIS CUTS KAZAKHMYS PRICE TARGET TO 280 (290) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
DEUTSCHE BANK CUTS SALAMANDER ENERGY TO 'HOLD' ('BUY') - TARGET 125 (185) PENCE
----------
JPMORGAN CUTS LONDON MINING TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 27 (100) PENCE
----------
CANACCORD CUTS CHARLES STANLEY GROUP PRICE TARGET TO 385 (480) PENCE - 'BUY'
----------
CITIGROUP CUTS LAMPRELL TO 'NEUTRAL' ('BUY') - TARGET 177 PENCE
----------
NUMIS CUTS PETROPAVLOVSK PRICE TARGET TO 30 (60) PENCE - 'SELL'
----------
NUMIS RAISES RIVER & MERCANTILE PRICE TARGET TO 238 (235) PENCE - 'ADD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.

Read more
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.